SUBSCRIBE
SUBSCRIBE
News   Business

Sterling to Buy Canadian Drug Plant

December 3, 2009 | 
1 min read
Bookmark and Share

in-pharmatechnologist.com -- Australia’s Sterling Products plans to buy a 4,310 sqm pharmaceutical manufacturing plant from a Canadian drugmaker that has fallen victim to the global economic crisis.
Real estate Asia Australia
MORE ON THIS TOPIC
Red and blue neon stairs going up to a cloud with dark background and reflections. 3d render
Earnings
Pfizer stays the course for 2026 guidance, dulling impact of Q1 earnings beat
May 5, 2026
 · 
2 min read
 · 
Annalee Armstrong
Stones in calm water with evening sun
Earnings
Vertex’s quiet Q1 is calm before potentially ‘iconic’ renal evolution
May 5, 2026
 · 
2 min read
 · 
Tristan Manalac
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Odyssey eyes $236M for renewed Nasdaq bid, Seaport docks on Nasdaq
May 5, 2026
 · 
12 min read
 · 
Editorial Team
pills Medicine tablet in blister pack on a yellow background
Manufacturing
Sertraline manufacturer recalls antidepressant batch after UK packaging mix-up
May 5, 2026
 · 
2 min read
 · 
Nick Paul Taylor